PMC:7035340 / 364-677 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"21","span":{"begin":38,"end":47},"obj":"Species"},{"id":"22","span":{"begin":108,"end":116},"obj":"Species"},{"id":"23","span":{"begin":234,"end":242},"obj":"Species"},{"id":"29","span":{"begin":23,"end":27},"obj":"Disease"},{"id":"30","span":{"begin":32,"end":36},"obj":"Disease"},{"id":"31","span":{"begin":248,"end":267},"obj":"Disease"}],"attributes":[{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"Tax:2697049"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"Tax:9606"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:9606"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:D045169"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:D018352"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"s (2.27%). Compared to SARS and MERS, 2019-nCoV appears to be much more contagious but less lethal, as most patients have mild symptoms and good prognosis1,2. However, according to the Chinese government’s daily report, 13.2–21.3% of patients with 2019-nCoV infection developed into severe or fatal illness (Fig. "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T4","span":{"begin":23,"end":27},"obj":"Disease"},{"id":"T5","span":{"begin":248,"end":267},"obj":"Disease"},{"id":"T6","span":{"begin":258,"end":267},"obj":"Disease"}],"attributes":[{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"s (2.27%). Compared to SARS and MERS, 2019-nCoV appears to be much more contagious but less lethal, as most patients have mild symptoms and good prognosis1,2. However, according to the Chinese government’s daily report, 13.2–21.3% of patients with 2019-nCoV infection developed into severe or fatal illness (Fig. "}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":11,"end":158},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"s (2.27%). Compared to SARS and MERS, 2019-nCoV appears to be much more contagious but less lethal, as most patients have mild symptoms and good prognosis1,2. However, according to the Chinese government’s daily report, 13.2–21.3% of patients with 2019-nCoV infection developed into severe or fatal illness (Fig. "}